Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT02391051
PHASE2
Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial
Sponsor: University of Erlangen-Nürnberg Medical School
View on ClinicalTrials.gov
Summary
This trial examines the feasibility and toxicity of focal brachytherapy in patients with low-risk prostate cancer.
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2014-10
Completion Date
2029-12
Last Updated
2017-08-11
Healthy Volunteers
No
Conditions
Interventions
RADIATION
HDR-Brachytherapy
HDR-Brachytherapy 2x 13,5 Gy
Locations (1)
University Hospital
Erlangen, Germany